Heart rate variability and Parkinson's disease severity
Identifieur interne : 003257 ( Main/Exploration ); précédent : 003256; suivant : 003258Heart rate variability and Parkinson's disease severity
Auteurs : D. Devos [France] ; M. Kroumova [France] ; R. Bordet [France] ; H. Vodougnon [France] ; J. D. Guieu [France] ; C. Libersa [France] ; A. Destee [France]Source :
- Journal of neural transmission [ 0300-9564 ] ; 2003.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
- Autonomic Nervous System Diseases (diagnosis), Autonomic Nervous System Diseases (etiology), Autonomic Nervous System Diseases (physiopathology), Autonomic nervous system, Cardiovascular System (physiopathology), Chronobiology Disorders (diagnosis), Chronobiology Disorders (etiology), Chronobiology Disorders (physiopathology), Disease Progression, Female, Heart Rate (drug effects), Heart Rate (physiology), Heart rate, Humans, Hypokinesia (complications), Hypokinesia (drug therapy), Hypokinesia (physiopathology), Levodopa (therapeutic use), Male, Middle Aged, Parkinson Disease (complications), Parkinson Disease (drug therapy), Parkinson Disease (physiopathology), Parkinson disease, Surveys and Questionnaires, Sympathetic Nervous System (physiopathology), Up-Regulation (drug effects), Up-Regulation (physiology), Vagus Nerve (physiopathology).
- MESH :
- chemical , therapeutic use : Levodopa.
- complications : Hypokinesia, Parkinson Disease.
- diagnosis : Autonomic Nervous System Diseases, Chronobiology Disorders.
- drug effects : Heart Rate, Up-Regulation.
- drug therapy : Hypokinesia, Parkinson Disease.
- etiology : Autonomic Nervous System Diseases, Chronobiology Disorders.
- physiology : Heart Rate, Up-Regulation.
- physiopathology : Autonomic Nervous System Diseases, Cardiovascular System, Chronobiology Disorders, Hypokinesia, Parkinson Disease, Sympathetic Nervous System, Vagus Nerve.
- Disease Progression, Female, Humans, Male, Middle Aged, Surveys and Questionnaires.
Abstract
Heart rate variability (HRV) decrease in Parkinson's disease (PD) could only be a consequence of reduce motor activity besides of being a marker of cardiovascular dysautonomia. Under continuously recorded and standardised motor activity, we studied thirty patients compared to controls in 3 PD stages: group I: less than 2 year-evolution, slight impaired without L-dopa; group II: mildly impaired with L-dopa; group III: advanced PD with motor complications. No difference was observed between group I and controls. The diurnal low frequency power (LF) and the ratio of LF/high frequency (HF) power decreased in groups II and III. The nocturnal vagal indicators: HF power and pNN50 were decreased in group III. Those parameters were correlated with Off-drug-motor handicap, suggesting an evolutive HRV decrease with disease severity but not with On-drug-motor activity. The low LF despite the higher motor activity in group III, due to dyskinesias, suggested a defective cardiovascular up-regulation.
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: 000E32
- to stream PascalFrancis, to step Curation: 000602
- to stream PascalFrancis, to step Checkpoint: 000D76
- to stream Main, to step Merge: 003739
- to stream PubMed, to step Corpus: 001081
- to stream PubMed, to step Curation: 001040
- to stream PubMed, to step Checkpoint: 001040
- to stream Ncbi, to step Merge: 000363
- to stream Ncbi, to step Curation: 000363
- to stream Ncbi, to step Checkpoint: 000363
- to stream Main, to step Merge: 003532
- to stream Main, to step Curation: 003257
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Heart rate variability and Parkinson's disease severity</title>
<author><name sortKey="Devos, D" sort="Devos, D" uniqKey="Devos D" first="D." last="Devos">D. Devos</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, EA 2683, CHU Lille</s1>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
<wicri:noRegion>CHU Lille</wicri:noRegion>
<wicri:noRegion>Department of Neurology, EA 2683, CHU Lille</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kroumova, M" sort="Kroumova, M" uniqKey="Kroumova M" first="M." last="Kroumova">M. Kroumova</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Clinical Investigation Center CHU-INSERM, CHU Lille</s1>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<wicri:noRegion>CHU Lille</wicri:noRegion>
<wicri:noRegion>Clinical Investigation Center CHU-INSERM, CHU Lille</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bordet, R" sort="Bordet, R" uniqKey="Bordet R" first="R." last="Bordet">R. Bordet</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Pharmacology, EA 1046,CHU Lille</s1>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>France</country>
<wicri:noRegion>CHU Lille</wicri:noRegion>
<wicri:noRegion>Department of Pharmacology, EA 1046,CHU Lille</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Vodougnon, H" sort="Vodougnon, H" uniqKey="Vodougnon H" first="H." last="Vodougnon">H. Vodougnon</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Clinical Investigation Center CHU-INSERM, CHU Lille</s1>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<wicri:noRegion>CHU Lille</wicri:noRegion>
<wicri:noRegion>Clinical Investigation Center CHU-INSERM, CHU Lille</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Guieu, J D" sort="Guieu, J D" uniqKey="Guieu J" first="J. D." last="Guieu">J. D. Guieu</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Department of Clinical Neurophysiology, EA 2683, CHU Lille</s1>
<s3>FRA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>France</country>
<wicri:noRegion>CHU Lille</wicri:noRegion>
<wicri:noRegion>Department of Clinical Neurophysiology, EA 2683, CHU Lille</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Libersa, C" sort="Libersa, C" uniqKey="Libersa C" first="C." last="Libersa">C. Libersa</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Clinical Investigation Center CHU-INSERM, CHU Lille</s1>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<wicri:noRegion>CHU Lille</wicri:noRegion>
<wicri:noRegion>Clinical Investigation Center CHU-INSERM, CHU Lille</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Destee, A" sort="Destee, A" uniqKey="Destee A" first="A." last="Destee">A. Destee</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, EA 2683, CHU Lille</s1>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
<wicri:noRegion>CHU Lille</wicri:noRegion>
<wicri:noRegion>Department of Neurology, EA 2683, CHU Lille</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">04-0220992</idno>
<date when="2003">2003</date>
<idno type="stanalyst">PASCAL 04-0220992 INIST</idno>
<idno type="RBID">Pascal:04-0220992</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000E32</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000602</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000D76</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000D76</idno>
<idno type="wicri:doubleKey">0300-9564:2003:Devos D:heart:rate:variability</idno>
<idno type="wicri:Area/Main/Merge">003739</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:12928836</idno>
<idno type="wicri:Area/PubMed/Corpus">001081</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001081</idno>
<idno type="wicri:Area/PubMed/Curation">001040</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001040</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001040</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001040</idno>
<idno type="wicri:Area/Ncbi/Merge">000363</idno>
<idno type="wicri:Area/Ncbi/Curation">000363</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000363</idno>
<idno type="wicri:doubleKey">0300-9564:2003:Devos D:heart:rate:variability</idno>
<idno type="wicri:Area/Main/Merge">003532</idno>
<idno type="wicri:Area/Main/Curation">003257</idno>
<idno type="wicri:Area/Main/Exploration">003257</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Heart rate variability and Parkinson's disease severity</title>
<author><name sortKey="Devos, D" sort="Devos, D" uniqKey="Devos D" first="D." last="Devos">D. Devos</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, EA 2683, CHU Lille</s1>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
<wicri:noRegion>CHU Lille</wicri:noRegion>
<wicri:noRegion>Department of Neurology, EA 2683, CHU Lille</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kroumova, M" sort="Kroumova, M" uniqKey="Kroumova M" first="M." last="Kroumova">M. Kroumova</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Clinical Investigation Center CHU-INSERM, CHU Lille</s1>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<wicri:noRegion>CHU Lille</wicri:noRegion>
<wicri:noRegion>Clinical Investigation Center CHU-INSERM, CHU Lille</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bordet, R" sort="Bordet, R" uniqKey="Bordet R" first="R." last="Bordet">R. Bordet</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Pharmacology, EA 1046,CHU Lille</s1>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>France</country>
<wicri:noRegion>CHU Lille</wicri:noRegion>
<wicri:noRegion>Department of Pharmacology, EA 1046,CHU Lille</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Vodougnon, H" sort="Vodougnon, H" uniqKey="Vodougnon H" first="H." last="Vodougnon">H. Vodougnon</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Clinical Investigation Center CHU-INSERM, CHU Lille</s1>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<wicri:noRegion>CHU Lille</wicri:noRegion>
<wicri:noRegion>Clinical Investigation Center CHU-INSERM, CHU Lille</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Guieu, J D" sort="Guieu, J D" uniqKey="Guieu J" first="J. D." last="Guieu">J. D. Guieu</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Department of Clinical Neurophysiology, EA 2683, CHU Lille</s1>
<s3>FRA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>France</country>
<wicri:noRegion>CHU Lille</wicri:noRegion>
<wicri:noRegion>Department of Clinical Neurophysiology, EA 2683, CHU Lille</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Libersa, C" sort="Libersa, C" uniqKey="Libersa C" first="C." last="Libersa">C. Libersa</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Clinical Investigation Center CHU-INSERM, CHU Lille</s1>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<wicri:noRegion>CHU Lille</wicri:noRegion>
<wicri:noRegion>Clinical Investigation Center CHU-INSERM, CHU Lille</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Destee, A" sort="Destee, A" uniqKey="Destee A" first="A." last="Destee">A. Destee</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, EA 2683, CHU Lille</s1>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
<wicri:noRegion>CHU Lille</wicri:noRegion>
<wicri:noRegion>Department of Neurology, EA 2683, CHU Lille</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Journal of neural transmission</title>
<title level="j" type="abbreviated">J. neural transm.</title>
<idno type="ISSN">0300-9564</idno>
<imprint><date when="2003">2003</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Journal of neural transmission</title>
<title level="j" type="abbreviated">J. neural transm.</title>
<idno type="ISSN">0300-9564</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Autonomic Nervous System Diseases (diagnosis)</term>
<term>Autonomic Nervous System Diseases (etiology)</term>
<term>Autonomic Nervous System Diseases (physiopathology)</term>
<term>Autonomic nervous system</term>
<term>Cardiovascular System (physiopathology)</term>
<term>Chronobiology Disorders (diagnosis)</term>
<term>Chronobiology Disorders (etiology)</term>
<term>Chronobiology Disorders (physiopathology)</term>
<term>Disease Progression</term>
<term>Female</term>
<term>Heart Rate (drug effects)</term>
<term>Heart Rate (physiology)</term>
<term>Heart rate</term>
<term>Humans</term>
<term>Hypokinesia (complications)</term>
<term>Hypokinesia (drug therapy)</term>
<term>Hypokinesia (physiopathology)</term>
<term>Levodopa (therapeutic use)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Parkinson Disease (complications)</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Parkinson Disease (physiopathology)</term>
<term>Parkinson disease</term>
<term>Surveys and Questionnaires</term>
<term>Sympathetic Nervous System (physiopathology)</term>
<term>Up-Regulation (drug effects)</term>
<term>Up-Regulation (physiology)</term>
<term>Vagus Nerve (physiopathology)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Levodopa</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Hypokinesia</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Autonomic Nervous System Diseases</term>
<term>Chronobiology Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Heart Rate</term>
<term>Up-Regulation</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Hypokinesia</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Autonomic Nervous System Diseases</term>
<term>Chronobiology Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Heart Rate</term>
<term>Up-Regulation</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Autonomic Nervous System Diseases</term>
<term>Cardiovascular System</term>
<term>Chronobiology Disorders</term>
<term>Hypokinesia</term>
<term>Parkinson Disease</term>
<term>Sympathetic Nervous System</term>
<term>Vagus Nerve</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Disease Progression</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Surveys and Questionnaires</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Rythme cardiaque</term>
<term>Système nerveux autonome</term>
<term>Parkinson maladie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Heart rate variability (HRV) decrease in Parkinson's disease (PD) could only be a consequence of reduce motor activity besides of being a marker of cardiovascular dysautonomia. Under continuously recorded and standardised motor activity, we studied thirty patients compared to controls in 3 PD stages: group I: less than 2 year-evolution, slight impaired without L-dopa; group II: mildly impaired with L-dopa; group III: advanced PD with motor complications. No difference was observed between group I and controls. The diurnal low frequency power (LF) and the ratio of LF/high frequency (HF) power decreased in groups II and III. The nocturnal vagal indicators: HF power and pNN50 were decreased in group III. Those parameters were correlated with Off-drug-motor handicap, suggesting an evolutive HRV decrease with disease severity but not with On-drug-motor activity. The low LF despite the higher motor activity in group III, due to dyskinesias, suggested a defective cardiovascular up-regulation.</div>
</front>
</TEI>
<affiliations><list><country><li>France</li>
</country>
</list>
<tree><country name="France"><noRegion><name sortKey="Devos, D" sort="Devos, D" uniqKey="Devos D" first="D." last="Devos">D. Devos</name>
</noRegion>
<name sortKey="Bordet, R" sort="Bordet, R" uniqKey="Bordet R" first="R." last="Bordet">R. Bordet</name>
<name sortKey="Destee, A" sort="Destee, A" uniqKey="Destee A" first="A." last="Destee">A. Destee</name>
<name sortKey="Guieu, J D" sort="Guieu, J D" uniqKey="Guieu J" first="J. D." last="Guieu">J. D. Guieu</name>
<name sortKey="Kroumova, M" sort="Kroumova, M" uniqKey="Kroumova M" first="M." last="Kroumova">M. Kroumova</name>
<name sortKey="Libersa, C" sort="Libersa, C" uniqKey="Libersa C" first="C." last="Libersa">C. Libersa</name>
<name sortKey="Vodougnon, H" sort="Vodougnon, H" uniqKey="Vodougnon H" first="H." last="Vodougnon">H. Vodougnon</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003257 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003257 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= ParkinsonFranceV1 |flux= Main |étape= Exploration |type= RBID |clé= Pascal:04-0220992 |texte= Heart rate variability and Parkinson's disease severity }}
![]() | This area was generated with Dilib version V0.6.29. | ![]() |